Cargando…
Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
BACKGROUND: Evidence is growing that low-dose aspirin used as an adjuvant treatment of cancer is associated with an increased survival and a reduction in metastatic spread. We therefore extended up to August 2017 an earlier systematic search and meta-analyses of published studies of low-dose aspirin...
Autores principales: | Elwood, Peter C., Pickering, Janet E., Morgan, Gareth, Galante, Julieta, Weightman, Alison L., Morris, Delyth, Longley, Marcus, Mason, Malcolm, Adams, Richard, Dolwani, Sunil, Chia W. K., John, Lanas, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155524/ https://www.ncbi.nlm.nih.gov/pubmed/30252883 http://dx.doi.org/10.1371/journal.pone.0203957 |
Ejemplares similares
-
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
por: Elwood, Peter C., et al.
Publicado: (2016) -
Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers
por: Elwood, Peter C, et al.
Publicado: (2021) -
Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk
por: Elwood, Peter C., et al.
Publicado: (2016) -
Healthy living and cancer: evidence from UK Biobank
por: Elwood, Peter C, et al.
Publicado: (2018) -
Aspirin and cancer: biological mechanisms and clinical outcomes
por: Elwood, Peter, et al.
Publicado: (2022)